NASDAQ · AKAN
Healthcare · Drug Manufacturers - Specialty & Generic
$2.66
Up+$0.10 (+3.76%)
Updated Sep 16, 2026, 2:48 PM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
AKAN closed at $2.66 after 20 trading sessions, down 45.27% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.75 | $2.83 | $2.64 | $2.66 | 172.43K |
| Sep 14, 2026 | $3.04 | $3.05 | $2.73 | $2.79 | 225.93K |
| Sep 11, 2026 | $3.09 | $3.31 | $3.03 | $3.07 | 332.98K |
| Sep 10, 2026 | $3.24 | $3.3284 | $3.00 | $3.00 | 256.74K |
| Sep 9, 2026 | $3.28 | $3.35 | $3.1578 | $3.25 | 256.87K |
| Sep 8, 2026 | $3.47 | $3.4802 | $3.2101 | $3.28 | 587.24K |
| Sep 4, 2026 | $4.36 | $4.44 | $3.27 | $3.35 | 21.66M |
| Sep 3, 2026 | $3.78 | $3.78 | $3.65 | $3.67 | 2.3M |
| Sep 2, 2026 | $3.68 | $3.78 | $3.43 | $3.74 | 87.5K |
| Sep 1, 2026 | $3.90 | $3.9047 | $3.63 | $3.70 | 105.08K |
| Aug 31, 2026 | $3.81 | $4.12 | $3.78 | $4.075 | 105.2K |
| Aug 28, 2026 | $4.15 | $4.2299 | $3.75 | $3.89 | 199.06K |
| Aug 27, 2026 | $4.18 | $4.33 | $3.97 | $4.23 | 161.17K |
| Aug 26, 2026 | $4.40 | $4.43 | $4.05 | $4.24 | 348.26K |
| Aug 25, 2026 | $3.66 | $5.20 | $3.60 | $4.95 | 1.61M |
| Aug 24, 2026 | $3.89 | $3.9111 | $3.64 | $3.705 | 109.18K |
| Aug 21, 2026 | $3.96 | $4.00 | $3.77 | $3.86 | 164.81K |
| Aug 20, 2026 | $3.98 | $4.0299 | $3.85 | $3.90 | 154.79K |
| Aug 19, 2026 | $4.44 | $4.46 | $3.97 | $4.06 | 361.91K |
| Aug 18, 2026 | $5.07 | $5.3074 | $4.7288 | $4.86 | 485.65K |
The latest Smart Investors Daily articles mentioning AKAN.
AKAN research
Company profile and research snapshot.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Sep 4, 2026
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. Genelux (NASDAQ:GNLX) stock moved upwards by
Yahoo · Sep 4, 2026
Akanda (NASDAQ:AKAN) subsidiary First Towers & Fiber has collected its first cash lease payment from a new 200-kilometer fiber network in Mexico, marking the shift from network construction to recurring revenue generation as the business discusses a potential expansion with its client. Key Investor TakeawaysAkanda (NASDAQ:AKAN) subsidiary First Towers & Fiber collected its first cash lease payment from the 200-kilometer fiber network in August 2026.
Yahoo · Sep 4, 2026
Toronto, Ontario--(Newsfile Corp. - September 4, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, today announced a series of operational and financial milestones that mark a significant step forward in the Company's transition into a recurring revenue-generating telecommunications infrastructure business.First Cash Lease Payment CollectedFTF...
Benzinga · Sep 4, 2026
Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AKAN.
No results
No recent SID articles mention AKAN.
